FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FBI Warns of FTP Cybersecurity Risk

Attorney Kate Stewart says the FBI is warning about the cybersecurity risk in FTP servers in healthcare facilities operated in an anonymous configurat...

Federal Register

Comment Period Extended on Animal DNA Guidance

Federal Register notice: FDA extends the comment period for the draft guidance for industry #187 Regulation of Intentionally Altered Genomic DNA in An...

Federal Register

FDA Exempts 71 Class 1 Devices from 510(k) Submissions

Federal Register notice: FDA identifies 71 Class 1 devices that are now exempt from premarket notification requirements.

Human Drugs

REMS No Longer Needed for Amgens Anemia Drugs: FDA

FDA determines that Amgens erythropoiesis-stimulating agents epoetin alfa (Procrit and Epogen) and darbepoetin alfa (Aranesp) no longer require a Risk...

Medical Devices

Quality System Violations Found at Abbotts St. Jude Medical

FDA warns Abbott about QS violations at its Sylmar, CA, manufacturing facility.

FDA General

Former CEO Pleads Guilty in Counterfeit Labels Case

The former CEO of Action Packing and Design, Paul Rodriguez, pleads guilty to trafficking in counterfeit labels and packaging.

Medical Devices

FDA Clears Ventec Life Systems Ventilation Device

FDA clears a Ventec Life Systems 510(k) for VOCSN, a portable life support device that combines five respiratory therapies ventilation, oxygen, cough...

Medical Devices

FDA Clears United Orthopedic Knee Insert

FDA clears a United Orthopedic 510(k) for its E-XPE polyethylene knee insert that is designed to provide patients with knee replacements with reduced ...

Medical Devices

FDA Allows Philips IntelliSite System Marketing

FDA permits marketing of the Philips IntelliSite Pathology Solution whole slide digital imaging system.

Human Drugs

Purdue Resubmits Butrans Petition to FDA

Purdue resubmits at the suggestion of FDA its petition asking for restrictions to ensure the safety and effectiveness of follow-on products citing But...